An Act To Change The Size And Composition Of The Board Of Directors Of The Maine Health Data Organization

LD 645 reduces the Maine Health Data Organization's board of directors from 20 to 12 voting members and adds a pharmaceutical industry representative as a voting member. It removes the previous requirement for staggered initial terms and makes the organization's executive director a nonvoting board member. The bill maintains representation for consumers, employers, healthcare providers (including hospitals, physicians, pharmacists, and mental health providers), and third-party payors, but streamlines the structure. This change directly affects how the board is composed and appointed, with the pharmaceutical industry now having a dedicated voting seat. The bill does not alter the organization's core purpose of managing health data for public health policy.